Obesity Treatment: Calibrate CEO on Medication & Lifestyle
- The future of obesity treatment hinges on integrating drug therapies with lifestyle interventions led by clinicians, according to Rob MacNaughton, CEO of Calibrate.
- This integrated model not onyl helps individuals maintain weight loss but also aims to improve healthcare outcomes while lowering costs.
- MacNaughton's insights highlight how combining medication with lifestyle adjustments can transform obesity treatment, delivering significant and lasting health benefits.
Rob MacNaughton, CEO of Calibrate, reveals the future of obesity treatment: a powerful integration of medication with lifestyle changes. This groundbreaking approach, highlighted in this News Directory 3 feature, prioritizes lasting weight loss outcomes. Discover how Calibrate is revolutionizing weight management through a combination of drug therapies and lifestyle interventions tailored for lasting health. This innovative model aims to improve healthcare results and lower costs, emphasizing clinical integrity. MacNaughton’s insights showcase how combining medication with lifestyle adjustments can transform obesity treatment, delivering meaningful health benefits. Through ongoing research, Calibrate is continuously refining its integrated approach, optimizing medication strategies. Discover what’s next as the company pushes the boundaries of effective and sustainable solutions.
Calibrate CEO Discusses Future of Obesity Treatment
Updated June 22, 2025
The future of obesity treatment hinges on integrating drug therapies with lifestyle interventions led by clinicians, according to Rob MacNaughton, CEO of Calibrate. MacNaughton says Calibrate is pioneering a weight management approach that combines anti-obesity medications with lifestyle changes to ensure lasting results.
This integrated model not onyl helps individuals maintain weight loss but also aims to improve healthcare outcomes while lowering costs. MacNaughton stressed Calibrate’s dedication to clinical integrity and ongoing research into safely reducing medication dosages and ensuring long-term success in weight management.
MacNaughton’s insights highlight how combining medication with lifestyle adjustments can transform obesity treatment, delivering significant and lasting health benefits.
What’s next
Calibrate plans to continue its research into optimizing medication tapering strategies and refining its integrated approach to provide even more effective and sustainable weight management solutions.